These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2397084

  • 1. Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.
    Tanganelli S, Fuxe K, von Euler G, Eneroth P, Agnati LF, Ungerstedt U.
    J Neural Transm Gen Sect; 1990; 81(3):183-94. PubMed ID: 2397084
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The ontogeny of apomorphine-induced alterations of neostriatal dopamine release: effects on spontaneous release.
    Andersen SL, Gazzara RA.
    J Neurochem; 1993 Dec; 61(6):2247-55. PubMed ID: 8245975
    [Abstract] [Full Text] [Related]

  • 9. The D1 agonist SKF 38393 increases dopamine release in the developing rat striatum.
    Walters DE, Howard SG.
    Eur J Pharmacol; 1990 Aug 10; 184(2-3):257-64. PubMed ID: 2150376
    [Abstract] [Full Text] [Related]

  • 10. Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis.
    Zetterström T, Ungerstedt U.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):29-36. PubMed ID: 6199219
    [Abstract] [Full Text] [Related]

  • 11. Striatal dopamine metabolism in response to apomorphine: the effects of repeated amphetamine pretreatment.
    Kuczenski R, Leith NJ, Applegate CD.
    Brain Res; 1983 Jan 10; 258(2):333-7. PubMed ID: 6824917
    [Abstract] [Full Text] [Related]

  • 12. Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum.
    Tanganelli S, Li XM, Ferraro L, Von Euler G, O'Connor WT, Bianchi C, Beani L, Fuxe K.
    Eur J Pharmacol; 1993 Jan 12; 230(2):159-66. PubMed ID: 8422898
    [Abstract] [Full Text] [Related]

  • 13. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1987 Mar 12; 39(3):196-202. PubMed ID: 2883284
    [Abstract] [Full Text] [Related]

  • 14. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA, Boyar WC, Oei E, Wood PL.
    Brain Res; 1988 Sep 13; 460(1):76-82. PubMed ID: 3219572
    [Abstract] [Full Text] [Related]

  • 15. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J, Coviella IL, Wurtman RJ.
    Neuropharmacology; 1984 Dec 13; 23(12A):1403-6. PubMed ID: 6543245
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW, Slimovitch C, Toffano G.
    Br J Pharmacol; 1990 Apr 13; 99(4):741-9. PubMed ID: 2361171
    [Abstract] [Full Text] [Related]

  • 17. Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.
    Diggory GL, Buckett WR.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):257-63. PubMed ID: 6510470
    [Abstract] [Full Text] [Related]

  • 18. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG, Roth RH.
    Brain Res; 1981 Feb 02; 205(2):313-9. PubMed ID: 7470869
    [Abstract] [Full Text] [Related]

  • 19. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM.
    Eur J Pharmacol; 1980 Jun 13; 64(2-3):123-32. PubMed ID: 6105080
    [Abstract] [Full Text] [Related]

  • 20. Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum.
    Kashihara K, Fukuda K, Sato M, Otsuki S.
    Neurosci Res; 1987 Jun 13; 4(5):428-32. PubMed ID: 3670749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.